142 filings
Page 3 of 8
8-K
u6iy1t
28 Jun 21
Departure of Directors or Certain Officers
5:02pm
8-K
sfn4r36i f5rs4pu1
1 Jun 21
Entry into a Material Definitive Agreement
8:41am
8-K
aess85oz5 zg
12 May 21
Departure of Directors or Certain Officers
4:21pm
8-K
4jf6zcqrra 74
6 May 21
Mirati Therapeutics Reports First Quarter 2021 Financial Results
4:28pm
8-K
tmy6k6adznmf
30 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
1kazbk 50oya
25 Feb 21
Mirati Therapeutics Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Corporate Updates
4:31pm
8-K
xhyk60t7r7jhq9
11 Jan 21
Regulation FD Disclosure
7:31am
8-K
je4z0t s44h8y7k9p
4 Nov 20
Mirati Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights
4:36pm
8-K
hn2bbeci5zqe3k
28 Oct 20
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
4:38pm
8-K
jxpals4 ds
26 Oct 20
Results of Operations and Financial Condition
4:53pm
8-K
ev4sh8trsj cw8
26 Oct 20
Regulation FD Disclosure
8:00am
8-K
rovy onyk6h01rlhlx
6 Aug 20
Mirati Therapeutics Reports Second Quarter 2020 Financial Results and Recent Business Highlights
4:19pm
8-K
gc8f7ct3nvi8sw
2 Jul 20
Entry into a Material Definitive Agreement
4:09pm
8-K
ed4w d94bpjba
18 May 20
Departure of Directors or Certain Officers
4:43pm
8-K
76phuzol
12 May 20
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
6hzijp3s0pbzo1cg l7x
7 May 20
Mirati Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Updates
4:18pm
8-K
c1rwao3q
25 Feb 20
Mirati Therapeutics Reports Year-end 2019 Financial Results and Recent Corporate Updates
8:21am
8-K
zr278sfkfl9 uhxu0
13 Jan 20
Results of Operations and Financial Condition
6:31am
8-K
33pzwale60kiec
10 Jan 20
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
8-K
a5qxdq7l87
6 Jan 20
Mirati Therapeutics Announces Executive Management Changes
4:41pm